Mesoblast in Freefall, page-883

Did those same "expert commentators" recommend everyone cash out of the market last week to avoid the carnage that has been this week? If they did not, why should anyone believe a single thing they say.

Anyone can look at the last quarterly and see what the cash balance is, cash burn and figure out when they may need a capital raise. I'm simply pointing out now they are right next to commercialization, they have several big partners, their product has proven safe and effective beyond the expectations of the company... and in that context you would question weather they are able to cash raise?

They were less likely to be able to cash raise 5 years ago before they demonstrated 40% ARDS mortality reduction, 50% CHF mace reduction, 100% remission in crohns patients, 50% average reduction in pain for CLBP........ and now they get 10 million plus USD a year from Japanese salies,..... and Alofisel is about to ramp up it's royalty payments.......and they can't raise capital???????